Echo Therapeutics Inc fka ECTE

[seeker_of_value]

Don't be so sure that being low priced is always a bargain. The company has to pay the high salary of Mooney. They burn cash constantly. If they cannot raise cash again the company can go to zero because it cannot commercialize Symphony. If the market cap is too low (like now) the company cannot raise cash. Also the market cap is not 12 million, but 27 M since now we have ~ 11 M shares outstanding (old 6+ and new 4+).

What I do not understand is how a public company CEO can be this bad and still survive. Mooney has messed everything - Investors, wall street, partners. The company image has been destroyed so bad that it is close to bankruptcy now. That is why the selling continued below $2.70. Still the board lets him remain. The stock price better rise to $5 level where raising cash will remain possible, else it will fall to zero.